|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q116774494
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000047.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q116774494
|
|
035
|
|
|
‡a
(OCoLC)Q116774494
|
|
100
|
0 |
|
‡a
Conrado Marques
‡c
researcher
‡9
en
|
|
670
|
|
|
‡a
Author's (+)-Limonene 1,2-Epoxide-Loaded SLNs: Evaluation of Drug Release, Antioxidant Activity, and Cytotoxicity in an HaCaT Cell Line
|
|
670
|
|
|
‡a
Author's Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines
|
|
919
|
|
|
‡a
perillaldehyde12epoxideloadedslntailoredmabproductionphysicochemicalcharacterizationandinvitrocytotoxicityprofileinmcf7celllines
‡A
Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines
‡9
1
|
|
919
|
|
|
‡a
+limonene12epoxideloadedslnsevaluationofdrugreleaseantioxidantactivityandcytotoxicityinanhacatcellline
‡A
(+)-Limonene 1,2-Epoxide-Loaded SLNs: Evaluation of Drug Release, Antioxidant Activity, and Cytotoxicity in an HaCaT Cell Line
‡9
1
|
|
996
|
|
|
‡2
PTBNP|1763968
|
|
996
|
|
|
‡2
RERO|A018711268
|
|
996
|
|
|
‡2
LC|n 86853770
|
|
996
|
|
|
‡2
NTA|436965577
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
